Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

2017 Board of Directors

Jan 03, 2017

PDA is pleased to announce the results of the 2017 Board of Directors election.

Directors

Congratulations to the following Directors elected by PDA’s membership to the board:

  • Barbara M. Allen, PhD, Senior Director, Global Quality Systems, Eli Lilly & Company, looks forward to shaping “the future to meet the needs of each of the members.”
  • Joyce Bloomfield sees this as her opportunity to continue doing “all that I can do to lead the advancement of medicine and manufacturing technology in order to facilitate availability of medicine to patients everywhere.”
  • Véronique Davoust, PharmD, Senior Manager, Global Quality Intelligence, Pfizer, wants to contribute “even more actively to the success of PDA by enhancing PDA’s activities in influencing regulations in the Quality/GMP arena.”
  • Ghada Haddad, Director, Global Quality Risk Management Center of Excellence, Merck, plans to “devote greater service to the PDA and its members by working to ensure quality, accuracy and relevance to the technical reports, the programs and training events.”

Outgoing Directors

PDA would also like to thank the following outgoing Directors for their service on the board:

  • Glenn Wright, Senior Director, Project Management TS/MS, Eli Lilly and Company
  • John Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting

Conversations

comments powered by Disqus